Arsanis, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
- Website
- http://www.arsanis.com
Prevention of S. Aureus Pneumonia Study in Mechanically Ventilated Subjects Who Are Heavily Colonized With S. Aureus.
Phase 2
Terminated
- Conditions
- Pneumonia, Ventilator-associatedPneumonia, Staphylococcal
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-10-21
- Last Posted Date
- 2019-07-31
- Lead Sponsor
- Arsanis, Inc.
- Target Recruit Count
- 155
- Registration Number
- NCT02940626
- Locations
- 🇬🇪
Research Site 268-007, Rustavi, Georgia
🇦🇹Research Site 040-002, Wien, Austria
🇬🇪Research Site 268-005, Tbilisi, Georgia
© Copyright 2025. All Rights Reserved by MedPath